HMGB1 and Alzheimer disease: Treatment of mouse microglial (N9) cell line with Aβ (1000 nM) was shown to upregulate HMGB1, IL-1β, and nod-like receptor protein 3 (NLRP3)-inflammasome, indicating a plausible contribution to microglial activation and subsequent inflammation in AD [36].